ArticlemedRxiv : the preprint server for health sciences2026

An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics.

Peter L Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.